BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24215903)

  • 1. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.
    Kawamura N; Ito Y; Sasaki M; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
    BMC Res Notes; 2013 Nov; 6():455. PubMed ID: 24215903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric injury caused by low-dose aspirin therapy in consecutive Japanese patients: a prospective study.
    Fukuda S; Hosaka S; Ozawa N; Akita S; Kashima T; Kimura S; Akiyama J; Mizoue T
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):275-9. PubMed ID: 22453536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin.
    Iwakiri R; Higuchi K; Kato M; Fujishiro M; Kinoshita Y; Watanabe T; Takeuchi T; Yamauchi M; Sanomura M; Nakagawa H; Sugisaki N; Okada Y; Ogawa H; Arakawa T; Fujimoto K
    Aliment Pharmacol Ther; 2014 Oct; 40(7):780-95. PubMed ID: 25100080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.
    Tamura I; Fujita T; Tsumura H; Morita Y; Yoshida M; Toyonaga T; Hirano S; Inokuchi H; Kutsumi H; Azuma T
    Intern Med; 2010; 49(23):2537-45. PubMed ID: 21139290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
    Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J; Saito Y; Honda A; Matsuzaki Y
    World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
    Sugano K; Matsumoto Y; Itabashi T; Abe S; Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Shimada K; Uchiyama S; Uemura N; Hiramatsu N
    J Gastroenterol; 2011 Jun; 46(6):724-35. PubMed ID: 21499703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury.
    Ito Y; Sasaki M; Noguchi S; Yamaguchi S; Okaniwa N; Tanabe A; Noda H; Yanamoto K; Tamura Y; Kondo Y; Masui R; Izawa S; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
    United European Gastroenterol J; 2013 Aug; 1(4):259-64. PubMed ID: 24917970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
    Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Uemura N; Hiramatsu N; Sugano K
    Hepatogastroenterology; 2013 Jun; 60(124):762-7. PubMed ID: 23478070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent].
    Ahn JY
    Korean J Gastroenterol; 2020 Nov; 76(5):238-241. PubMed ID: 33234770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
    Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.